HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amanda Labora Selected Research

Adenocarcinoma

1/2023MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell-intrinsic Amplification of Type I IFN Signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amanda Labora Research Topics

Disease

3Neoplasms (Cancer)
01/2023 - 01/2023
2Bites and Stings (Sting)
01/2023 - 01/2023
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 01/2023
1Neoplasm Metastasis (Metastasis)
03/2023
1Adenocarcinoma
01/2023
1Colonic Neoplasms (Colon Cancer)
01/2023
1Infections
01/2023

Drug/Important Bio-Agent (IBA)

2InterferonsIBA
01/2023 - 01/2023
1Biomarkers (Surrogate Marker)IBA
01/2023
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2023
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023
1DNA (Deoxyribonucleic Acid)IBA
01/2023
1Phosphotransferases (Kinase)IBA
01/2023
1RNA (Ribonucleic Acid)IBA
01/2023

Therapy/Procedure

2Therapeutics
01/2023 - 01/2023
1Intravenous Injections
03/2023
1Neoadjuvant Therapy
01/2023
1Lymph Node Excision (Lymph Node Dissection)
01/2023